divis
lead world-wide dental product manufactur acquir orametrix lead industri
provid technolog solut orthodont orametrix annual sale million
profit januari fda grant pre-market approv orametrix sureclear align
system estim dentspli could introduc sureclear soon upcom american associ
orthodontist annual session may sureclear allow dentspli better compet
cover domin approxim billion clear align market
invisalign product acquisit upcom sureclear introduct dentspli
comprehens orthodont offer includ plan softwar imag bracket wire well clear
align therefor abl offer appropri solut dentist/pati howev
dentspli plan addit invest penetr align space therefor orametrix
expect dilut ep around cent cent
addit dentspli new manag instruct distributor includ patterson dental compani
hold order dentspli product support retail demand vs previou practic
distributor order base project retail demand therefor expect order typic
receiv first quarter move remain three quarter year
result factor note ep estim cent vs cent year earlier
cent previous top-lin million ex-pm vs billion
ep estim vs record adjust compani guidanc
march previous revenu billion vs billion
compani guidanc billion compani guidanc includ materi share repurchas
forecast oper net margin ex-pm revenu respect vs
respect tax rate model vs new tax law reduc
valu dentspli foreign tax credit impact cent per share capit spend estim around
million exclud amort purchas intang around million
million dividend million result gross/fre cash flow per share
ep estim project revenu billion
forecast oper margin ex-pm revenu net interest expens model
million tax rate net margin project bp ex-pm revenu share
count model flat
pleas see import disclosur end report
share sell forward ep estim project
year ep growth rate rate hold share trade trail
price-to-report earn ratio current sell estim
ebitda million around estim ebitda billion
realiz expect revenue/cost synergi sirona major risk compound recent
manag chang middl integr compani investig sec
divis enforc regard account disclosur worth note pwc compani
auditor sign financi statement without request extens scrutin report
impact econom condit includ job loss procedur deferr trade-down result risk
sale outsid compani expos fx fluctuat well
effect sale forc abl satisfactorili servic countri gener reimburs
concern impact result signific impact outsid particularli
germani limit reimburs domest anoth consider regulatori environ
includ fda regul introduct manufactur advertis label packag market
distribut product
pleas see import disclosur end report
divis wellington shield co llc
-- earn model -- march
dec year-end
million except per share data
good sold
good sold
pleas see import disclosur end report
